Quanterix Corporation
QTRX
|
$16.9
3.68%
60K
|
Health Technology
(0.0% 1d) (-27.5% 1m) (29.6% 1y) (0.0% 2d) (0.0% 3d) (3.5% 7d) (7.36% volume)
Earnings Calendar: 2023-11-07
Market Cap: $ 646,375,618
http://www.quanterix.com
Sec Filling | Patents | 248 employees
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its Single Molecule Array (Simoa) technology platform uses single molecule measurements to access previously undetectable proteins. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.
diagnostics
add to watch list Paper trade email alert is off
Press-releases
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
Published: 2024-03-04 (Crawled : 16:00) - biospace.com/
QTRX | $16.9 3.68% 60K
|
Health Technology
|
| O: 3.7%
H: 1.64%
C: 0.25%
fda device disease test granted alzheimer’s designation
Multiplex Assays Markets, 2030
Published: 2024-03-01 (Crawled : 20:00) - prnewswire.com
QGEN | $41.58 0.87% 150K
|
Health Technology
| Email alert
Add to watchlist
QTRX | $16.9 3.68% 60K
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.51 0.41% 310K
|
Health Technology
| Email alert
Add to watchlist
BDX | $234.34 0.2% 84K
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.58 0.87% 150K
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $572.645 4.43% 800K
|
Health Technology
| Email alert
Add to watchlist
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023
Published: 2024-02-29 (Crawled : 23:00) - biospace.com/
QTRX | $16.9 3.68% 60K
|
Health Technology
|
| O: 1.66%
H: 2.37%
C: 0.38%
year results
Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease
Published: 2024-02-26 (Crawled : 14:30) - biospace.com/
QTRX | $16.9 3.68% 60K
|
Health Technology
|
| O: 0.08%
H: 2.45%
C: 0.8%
first management disease health alzheimer’s networks
Element Biosciences Welcomes William P. Donnelly to its Board of Directors
Published: 2023-11-21 (Crawled : 18:00) - biospace.com/
IR | $89.77 1.29% 190K
|
Producer Manufacturing
|
| O: -0.24%
H: 0.81%
C: 0.41%
QTRX | $16.9 3.68% 60K
|
Health Technology
|
| O: 0.13%
H: 2.41%
C: 1.64%
Azenta Announces Actions to Support Ongoing Strategic and Governance Transformation
Published: 2023-11-13 (Crawled : 21:00) - prnewswire.com
LAB | $2.615 2.95% 460K
|
Manufacturing
|
| O: 2.28%
H: 2.68%
C: -0.45%
AZTA | $52.65 3.42% 67K
|
n/a
|
| O: 11.73%
H: 4.57%
C: 1.93%
IFNNF | $32.231 410
|
Electronic Technology
|
| O: 6.02%
H: 0.74%
C: 0.74%
IFNNY | $32.09 550K
|
Manufacturing
|
| O: 5.16%
H: 0.62%
C: 0.0%
SOPH | $4.92 -1.8% 12K
|
|
| O: 1.24%
H: 20.4%
C: 12.58%
KN | $15.945 2.21% 96K
|
Electronic Technology
|
| O: 3.88%
H: 0.87%
C: 0.12%
A | $137.88 2.97% 250K
|
Health Technology
|
| O: 2.18%
H: 0.0%
C: 0.0%
CG | $46.14 2.08% 160K
|
Finance
|
| O: 2.47%
H: 3.93%
C: 3.45%
RGEN | $172.92 9.8% 230K
|
Health Technology
|
| O: 5.01%
H: 2.99%
C: 0.52%
QTRX | $16.9 3.68% 60K
|
Health Technology
|
| O: 5.75%
H: 3.56%
C: 3.52%
LOGI F | $81.27 -6.41% -6.85% 1.2M
|
Electronic Technology
|
| O: 3.1%
H: 0.0%
C: -0.26%
ongoing
Sotera Health Appoints Karen Flynn to Board of Directors
Published: 2023-11-13 (Crawled : 12:00) - globenewswire.com
SHC | $11.44 3.16% 150K
|
Commercial Services
|
| O: -0.08%
H: 1.31%
C: 1.0%
WST | $383.62 2.25% 44K
|
Health Technology
|
| O: -1.12%
H: 1.2%
C: 0.09%
CTLT | $56.005 -0.08% 220K
|
Health Technology
|
| O: -1.1%
H: 1.3%
C: -0.24%
QTRX | $16.9 3.68% 60K
|
Health Technology
|
| O: 0.0%
H: 1.07%
C: 0.98%
health
Quanterix Releases Operating Results for Third Quarter 202
Published: 2023-11-06 (Crawled : 00:00) - biospace.com/
JNJ | News | $148.24 -0.59% 1.6M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
QTRX | $16.9 3.68% 60K
|
Health Technology
|
| O: -0.92%
H: 1.07%
C: -2.86%
results
Quanterix to Report Third Quarter 2023 Financial Results on November 7, 2023
Published: 2023-10-30 (Crawled : 22:00) - biospace.com/
QTRX | $16.9 3.68% 60K
|
Health Technology
|
| O: 1.51%
H: 0.24%
C: -1.15%
report financial results
Quanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimer’s Disease
Published: 2023-10-24 (Crawled : 22:00) - biospace.com/
QTRX | $16.9 3.68% 60K
|
Health Technology
|
| O: 1.86%
H: 9.98%
C: 8.35%
disease test biomarker alzheimer’s blood
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 89% | 11% |
Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M
|
AGBA | $2.46 96.8% 28M
|
Finance
EDBL | News | $6.94 84.57% 1.4M
|
CZOO | $7.74 55.11% 2.7M
|
ZAPP | $6.02 35.59% 95K
|
n/a
OPRT | News | $3.01 33.78% 6.8M
|
Finance
MLEC | $1.81 29.29% 2M
|
n/a
MTC | $2.0 28.21% 1.7M
|
Technology Services
PEGY | $0.0586 27.95% 130M
|
Manufacturing
VNRX | $0.759 26.5% 390K
|
Health Technology
Last 48 Hours Insiders Buying
ETST P 79000 | $0.065 110K
|
Manufacturing
|
11:30
MCFT P 26039 | $22.0 2.33% 29K
|
Consumer Durables
|
00:00
YORW P 29 | $35.42 8K
|
Utilities
|
19:01
VUZI P 14500 | $1.35 48K
|
Electronic Technology
|
17:00
BANF P 256 | $92.43 1.26% 5.7K
|
Finance
|
15:30
RMCF | $3.57 170
|
Consumer Non-Durables
|
20:10